Oncology & Cancer

Rare angiosarcoma tumors respond well to immunotherapy combination

Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute's (NCI) Division of Cancer Diagnosis and Treatment (DCTD), part of the National Institutes of Health, have ...

Oncology & Cancer

Immune cell linked to better lung cancer survival

Around 48,500 people are diagnosed with lung cancer in the UK each year. New treatments are desperately needed as fewer than 20% of patients survive for five years after diagnosis, and it is the biggest cause of death from ...

Oncology & Cancer

Talk between immune cells could lead to new cancer vaccine

In the past decade, immunotherapy has helped save the lives of many cancer patients, many with lung cancer, who might have otherwise faced almost certain death sentences. However, only about 20% of patients who received immune ...

page 9 from 40